KR840005815A - I-옥사세팜 화합물의 제조방법 - Google Patents

I-옥사세팜 화합물의 제조방법 Download PDF

Info

Publication number
KR840005815A
KR840005815A KR1019830003960A KR830003960A KR840005815A KR 840005815 A KR840005815 A KR 840005815A KR 1019830003960 A KR1019830003960 A KR 1019830003960A KR 830003960 A KR830003960 A KR 830003960A KR 840005815 A KR840005815 A KR 840005815A
Authority
KR
South Korea
Prior art keywords
general formula
methylene
aryl
substituted
hydroxy
Prior art date
Application number
KR1019830003960A
Other languages
English (en)
Other versions
KR900004149B1 (ko
Inventor
사다오(외 4) 야마모또
Original Assignee
요시또시 가즈오
시오노기세이야꾸 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 요시또시 가즈오, 시오노기세이야꾸 가부시끼가이샤 filed Critical 요시또시 가즈오
Publication of KR840005815A publication Critical patent/KR840005815A/ko
Application granted granted Critical
Publication of KR900004149B1 publication Critical patent/KR900004149B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/185—Saturated compounds having only one carboxyl group and containing keto groups
    • C07C59/21—Saturated compounds having only one carboxyl group and containing keto groups containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C245/00—Compounds containing chains of at least two nitrogen atoms with at least one nitrogen-to-nitrogen multiple bond
    • C07C245/12—Diazo compounds, i.e. compounds having the free valencies of >N2 groups attached to the same carbon atom
    • C07C245/14—Diazo compounds, i.e. compounds having the free valencies of >N2 groups attached to the same carbon atom having diazo groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C245/18—Diazo compounds, i.e. compounds having the free valencies of >N2 groups attached to the same carbon atom having diazo groups bound to acyclic carbon atoms of a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D505/00—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0834—Compounds having one or more O-Si linkage
    • C07F7/0892—Compounds with a Si-O-N linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/10—Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

내용 없음

Description

1-옥사세팜 화합물의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (7)

  1. 하기 일반식
    의 옥사졸리노아제티디논을 하기 일반식
    의 4-히드록시부티레이트와 반응시킴을 특징으로 하는 하기 일반식
    의 4-(임의 1-보호된-3α-아실아미노-2-옥소아제티딘-4β-일)옥시부티레이트의 제조방법.
    (상기 식들 중에서, R1은 임의 치환된 알킬, 아르알킬 또는 아릴이고, R2는 메틸렌, 히드록시이미노 메틸렌,보호된 히드록시이미노 메틸렌 또는 디아조메틸렌이며, X는 옥소 또는(엑소)메틸렌이고, Z는 수소 또는 N-보호기이다)
  2. 하기 일반식
    의 4-Y1-치환된-아세토아세테이트를 아릴술포닐아지드와 같은 디아조화제와 반응시킴을 특징으로 하는 하기 일반식
    의 2-디아조-4-Y1-치환된 아세토아세테이트의 제조방법.
    (상기 식들 중에서R은 에스테르 형성기이고 Y1은 히드록시, 보호된 히드록시 또는 일반식
    의 기(식중 R1은 임의 치환된 알킬, 아르알킬 또는 아릴이며 Z는 수소 또는 N-보호기이다)이다]
  3. 하기 일반식
    의 4-Y1-치환된 부티레이트를 산화질소 또는 아질산염과 같은 니트로실화제로 히드록시이민화 함을 특징으로 하는 하기 일반식
    의 2-히드록시이미노-4-Y1-치환된 부티레이트의 제조 방법.
    [상기 식들 중에서, R은 에스테르 형성기이고, X는 옥소 또는 메틸렌이며, Y1은 히드록시, 보호된 히드록시 또는 일반식
    의 기(식중 R1은 임의 치환된 알킬, 아랄킬 또는 아릴이며, Z는 수소 또는 N-보호기이다)이다.]
  4. 하기 일반식
    의 4-Y1-치환된-2-디아조-3-X-치환된 부티레이트를 아민화반응시킴을 특징으로 하는 하기 일반식
    의 4-Y1-치환된-2-디아조-3-X-치환된 부티레이트의 제조방법.
    [상기 식들 중에서, R은 에스테르 형성기이고, X는 옥소 또는 에틸렌이며, Y1은 히드록시, 보호된 히드록시 또는 일반식
    의 기(식중 R1은 임의 치환된 알킬, 아랄킬 또는 아릴이며, Z는 수소 또는 N-보호기이다)이다]
  5. 하기 일반식
    의 4-Y1-치환된-아세토아세테이트를 하기 일반식
    Ar3P=CH2
    의 포스포러스-일리드 시약으로 위티그 반응시킴을 특징으로 하는 하기 일반식
    의 3-Y1-치환된 메틸-3-부테노에이트의 제조방법.
    [상기 식들 중에서, R은 에스테르 형성기이고, R2는 메틸렌, 히드록시이마노메틸, 보호된 히드록시 이마노메틸렌 또는 디아조메틸렌이며, Y1은 히드록시, 보호된 히드록시 또는 일반식
    의 기(식중 R1은 임의 치환된 알킬, 아랄킬 또는 아릴이고, Z는 수소 또는 N-보호기이다)이고, Ar은 아릴이다.]
  6. 하기 일반식]
    의 4-(3α-아실아미노-2-옥소아제티딘-4-β-일)옥시-2-아조부티레이트를 분자내 카베노이드삽입반응시킴을 특징으로하는 하기 일반식
    의 7α-아실아미노-1-데티아-1-옥사세팜-4α-카르복실레이트의 제조방법.
    (상기 식들 중에서, R은 에스테르 형성기이고, R1은 임의 치환된 알킬, 아르알킬 또는 아릴이며, X는 옥소 또는 메틸렌이다.)
  7. 제 6 항에 있어서, 분자내 카베노이드 삽입 반응이 루이스산 존재하에 수행되는 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019830003960A 1982-08-24 1983-08-24 1-옥사세팜 화합물의 제조방법 KR900004149B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP82-147268 1982-08-24
JP57147268A JPS5936684A (ja) 1982-08-24 1982-08-24 １−オキサセフアム化合物の製造方法
JP147268 1982-08-24

Publications (2)

Publication Number Publication Date
KR840005815A true KR840005815A (ko) 1984-11-19
KR900004149B1 KR900004149B1 (ko) 1990-06-16

Family

ID=15426375

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019830003960A KR900004149B1 (ko) 1982-08-24 1983-08-24 1-옥사세팜 화합물의 제조방법

Country Status (12)

Country Link
US (1) US4539148A (ko)
EP (1) EP0102893B1 (ko)
JP (1) JPS5936684A (ko)
KR (1) KR900004149B1 (ko)
CA (1) CA1227482A (ko)
DE (1) DE3377276D1 (ko)
DK (1) DK385983A (ko)
GB (1) GB2126223B (ko)
GR (1) GR78932B (ko)
HU (1) HU191875B (ko)
IE (1) IE55873B1 (ko)
IL (1) IL69546A (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0115770B2 (en) * 1983-01-07 1996-06-19 Takeda Chemical Industries, Ltd. Thiazole Derivatives
JPH0830051B2 (ja) * 1986-05-21 1996-03-27 武田薬品工業株式会社 ４−ハロゲノ−２−置換オキシイミノ−３−オキソ酪酸のエステルまたはアミドの製造法
US4775745A (en) * 1986-12-08 1988-10-04 National Distillers And Chemical Corporation Diazonium compounds useful as components for nucleic acid probes
GB8707515D0 (en) * 1987-03-30 1987-05-07 Fujisawa Pharmaceutical Co Amino acid derivatives

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1345081A (en) * 1973-09-14 1974-01-30 Lonza Ag Process for the preparation of ypsilon-alkoxy-acetoacetic esters
US4011216A (en) * 1975-04-11 1977-03-08 Bristol-Myers Company Δ2,3-0-2-Isocephem-4-carboxylic acid and derivatives thereof as antibacterial agents
GB1533049A (en) * 1976-04-15 1978-11-22 Bristol Myers Canada Ltd O-2-isocephem compounds and their preparation
JPS604811B2 (ja) * 1976-07-28 1985-02-06 塩野義製薬株式会社 メチルケトンのハロゲン化
JPS5398951A (en) * 1977-02-08 1978-08-29 Shionogi & Co Ltd Azetidinone derivatives and process for their preparation
CH649984A5 (de) * 1981-06-17 1985-06-28 Lonza Ag 4-hydroxyacetessigsaeureethylester.
JPS58103391A (ja) * 1981-12-11 1983-06-20 Meiji Seika Kaisha Ltd １−オキサデチア−セフエム誘導体の製造法

Also Published As

Publication number Publication date
IE831936L (en) 1984-02-24
IE55873B1 (en) 1991-02-14
GB2126223B (en) 1986-06-04
EP0102893B1 (en) 1988-07-06
GB2126223A (en) 1984-03-21
CA1227482A (en) 1987-09-29
IL69546A0 (en) 1983-11-30
JPS5936684A (ja) 1984-02-28
IL69546A (en) 1988-03-31
GB8322116D0 (en) 1983-09-21
DK385983A (da) 1984-02-25
DK385983D0 (da) 1983-08-23
HU191875B (en) 1987-04-28
JPH0355475B2 (ko) 1991-08-23
KR900004149B1 (ko) 1990-06-16
EP0102893A1 (en) 1984-03-14
US4539148A (en) 1985-09-03
DE3377276D1 (en) 1988-08-11
GR78932B (ko) 1984-10-02

Similar Documents

Publication Publication Date Title
KR850001229A (ko) 4'-탈메틸-4-에피포도필로톡신 유도체의 제조방법
KR910001037A (ko) 포스포리파아제a₂억제제
DE2962643D1 (en) 3,5-dihydroxypentanoic ester derivatives having antihyperlipaemic activity, their manufacture and pharmaceutical compositions containing them
KR840007011A (ko) 세펨 화합물의 제조방법
KR840001145A (ko) 피리다진의 아미노 화합물의 제조방법
KR850001746A (ko) 퀴나졸린 화합물의 제조방법
KR840005815A (ko) I-옥사세팜 화합물의 제조방법
KR910007923A (ko) 3-(l-피로글루타밀)-l-티아졸리딘-4-카르복실산과 그 유도체의 제조방법
KR850001724A (ko) 4-페닐-4-옥소-부텐-2-오인산유도체의 제조방법
JPS6431752A (en) Amide derivative and skin external preparation containing said derivative
KR840005455A (ko) 세팔로스포린 유도체류의 제조방법
KR850007582A (ko) 모노아실 폴리알킬렌 폴리아민의 제조방법
KR850005413A (ko) 아미노니트로피리딘의 제조방법
KR850007800A (ko) 세팔로스포린 유도체의 에스테르 제조방법
KR850001742A (ko) 큐말산 에스테르의 제조방법
KR850005411A (ko) α-메틸-(6-펜옥시)-2- 피콜릴 사이클로프로판 카복실 레이트의 제조방법
KR880000372A (ko) 4-페닐-4-옥소-2-부테노산 유도체의 제조방법
KR910016673A (ko) 히드록시페닐프로피오네이트의 제조방법
KR840002774A (ko) 플루오로페녹시벤질 에스테르류의 제조방법
ES486377A1 (es) Procedimiento para la preparacion de 5-mercapto-1,2,3-tria- zoles
KR840004759A (ko) 페니실린과 세팔로스포린 화합물의 제조방법 및 이들의 제조에 사용한 새로운 중간체의 제조방법
KR830001265A (ko) 새로운 티아디아졸 화합물류와 그 제조방법
KR860001087A (ko) 치환된 1,3-디옥산의 제조방법
KR860004068A (ko) 세펨유도체의 간단한 제조방법
KR970010772A (ko) 7-아미노-3-메톡시메틸-3-세펨-4-카르복실산의 신규 제조방법

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19950202

Year of fee payment: 6

LAPS Lapse due to unpaid annual fee